FDA Drug recall D-0576-2022
Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd
- FDA Drug
- Class III
- terminated
- Published 2022-03-02
On 2022-03-02 the FDA classified a Class III recall of Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd by Dr Reddy S Laboratories, citing failed stability specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0576-2022 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2022-01-19 |
| Published | 2022-03-02 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-465-62
Reason
Failed stability specifications
Identifiers
| ndc | 43598-465-62 |
|---|---|
| code_info | Lot#: H200107, Exp 8/1/2023; H200154, Exp 9/1/2023; H210020, Exp 11/1/2023; H210055, Exp 12/1/2023; H210129, Exp 1/1/2024, H210288, Exp 4/1/2024. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0576-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.